NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 6,000 shares, a decrease of 46.9% from the June 15th total of 11,300 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 1.5 days.
NovAccess Global Stock Down 23.3 %
Shares of NovAccess Global stock opened at $0.15 on Friday. The company has a 50 day moving average of $0.24 and a 200-day moving average of $0.33. NovAccess Global has a 1-year low of $0.10 and a 1-year high of $0.96.
Get NovAccess Global alerts:NovAccess Global Company Profile
(Get Rating)
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.Read More
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- MarketBeat: Week in Review 7/11 – 7/15
- Is Coupang's Stock On The Verge Of A Turnaround?
- Should You Have These Two Banks In Your Portfolio?
- Verint Systems Stock is a Customer Engagement Play
- Why Shopify Stock Split...And is as Shoppable as Ever
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.